Maintenance agreement
Ended Awarded Last action
- Contract number
- 75N91024F90188
- Awardee
-
10X Genomics, Inc. UEI D1NLDEZ14TV5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,000
Award facts
- Contract value 100% obligated
- $12,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- North Bethesda, MD 20852, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$3,000 | |
| Original award | $15,000 |
About this award
The National Cancer Institute issued a BPA call to 10X Genomics, Inc. for a maintenance agreement with a ceiling value of $12,000.00, awarded September 21, 2024. Performance occurs at North Bethesda, Maryland, with an ultimate completion date of September 20, 2025. The call carries firm fixed price terms and was issued under a full-and-open procurement with no set-aside.
Quick answers
Who was awarded contract 75N91024F90188?
75N91024F90188 was awarded to 10X Genomics, Inc. by National Cancer Institute (National Institutes of Health) on September 21, 2024.
How much is contract 75N91024F90188 worth?
The government has obligated $12,000 on 75N91024F90188.
Is contract 75N91024F90188 an order under another contract?
Yes. 75N91024F90188 is a BPA call under 75N98022A00032, a blanket purchase agreement.
Was contract 75N91024F90188 competed?
The extent of competition for 75N91024F90188 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award